SOPHiA GENETICS (SOPH) Accumulated Expenses (2020 - 2026)

SOPHiA GENETICS has disclosed Accumulated Expenses across 7 years of filings, most recently posting $18.7 million for Q2 2026.

• In Q2 2026, Accumulated Expenses rose 36.27% year-over-year to $18.7 million; the TTM figure through Jun 2026 stood at $18.7 million (up 36.27% YoY), while the FY2025 annual figure was $20.7 million, up 56.89% from the prior year.
• Accumulated Expenses came in at $18.7 million for Q2 2026 at SOPHiA GENETICS, up from $13.4 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $20.7 million in Q4 2025 to a low of $10.5 million in Q1 2023.
• Average Accumulated Expenses over 5 years is $14.6 million, with a median of $13.8 million recorded in 2023.
• Year-over-year, Accumulated Expenses plunged 31.63% in 2023 and jumped 56.89% in 2025.
• Over 5 years, Accumulated Expenses stood at $14.5 million in 2022, then gained by 22.77% to $17.8 million in 2023, then dropped by 25.78% to $13.2 million in 2024, then jumped by 56.89% to $20.7 million in 2025, then fell by 9.82% to $18.7 million in 2026.
• Per Business Quant data, the three most recent Accumulated Expenses figures were $18.7 million in Q2 2026, $13.4 million in Q1 2026, and $20.7 million in Q4 2025.